Cornerstone Wealth Group LLC purchased a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,448 shares of the financial services provider’s stock, valued at approximately $200,000.
Other institutional investors have also recently made changes to their positions in the company. Blue Trust Inc. grew its holdings in MetLife by 26.7% during the 4th quarter. Blue Trust Inc. now owns 9,910 shares of the financial services provider’s stock worth $817,000 after acquiring an additional 2,088 shares in the last quarter. Kingswood Wealth Advisors LLC bought a new position in shares of MetLife during the fourth quarter valued at approximately $259,000. PFG Investments LLC increased its holdings in MetLife by 19.8% during the fourth quarter. PFG Investments LLC now owns 7,621 shares of the financial services provider’s stock valued at $624,000 after buying an additional 1,261 shares during the period. Stablepoint Partners LLC raised its stake in MetLife by 0.4% in the fourth quarter. Stablepoint Partners LLC now owns 57,317 shares of the financial services provider’s stock worth $4,693,000 after buying an additional 247 shares in the last quarter. Finally, Precedent Wealth Partners LLC boosted its position in MetLife by 1.8% during the 4th quarter. Precedent Wealth Partners LLC now owns 17,126 shares of the financial services provider’s stock valued at $1,402,000 after acquiring an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.
MetLife Stock Performance
Shares of MET stock opened at $86.97 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The business has a fifty day moving average of $83.81 and a 200 day moving average of $80.11. The firm has a market capitalization of $60.22 billion, a price-to-earnings ratio of 17.53, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05.
MetLife Dividend Announcement
Analyst Ratings Changes
Several research analysts have recently commented on the company. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. BMO Capital Markets assumed coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target for the company. JPMorgan Chase & Co. lifted their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Wells Fargo & Company decreased their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. Finally, Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $90.46.
Check Out Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Sizing Up a New Opportunity for NVIDIA Investors
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What Are Dividend Contenders? Investing in Dividend Contenders
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.